The University of Chicago Header Logo

Connection

Hemant Roy to Trans-Activators

Back to Details
This is a "connection" page, showing publications Hemant Roy has written about Trans-Activators.
Hemant Roy
Connection Strength
0.201
Trans-Activators
  1. The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits beta-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis. Cancer Lett. 2005 Jan 20; 217(2):161-9.
    View in: PubMed
    Score: 0.201
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.